Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions.
Duvuru GeethaAndreas KronbichlerMegan RutterDivya BajpaiSteven MenezAnnemarie WeissenbacherShuchi AnandEugene LinNicholas CarlsonStephen SozioKevin FowlerRay BignallKathryn DucharletElliot K TannorEranga WijewickramaMuhammad I A HafidzVladimir TesarRobert HooverDeidra CrewsCharles VarnellLara Danziger-IsakovVivekananda JhaSumit MohanChirag R ParikhValerie LuyckxPublished in: Nature reviews. Nephrology (2022)
The coronavirus disease 2019 (COVID-19) pandemic has disproportionately affected patients with kidney disease, causing significant challenges in disease management, kidney research and trainee education. For patients, increased infection risk and disease severity, often complicated by acute kidney injury, have contributed to high mortality. Clinicians were faced with high clinical demands, resource shortages and novel ethical dilemmas in providing patient care. In this review, we address the impact of COVID-19 on the entire spectrum of kidney care, including acute kidney injury, chronic kidney disease, dialysis and transplantation, trainee education, disparities in health care, changes in health care policies, moral distress and the patient perspective. Based on current evidence, we provide a framework for the management and support of patients with kidney disease, infection mitigation strategies, resource allocation and support systems for the nephrology workforce.
Keyphrases
- healthcare
- end stage renal disease
- chronic kidney disease
- acute kidney injury
- coronavirus disease
- peritoneal dialysis
- cardiac surgery
- public health
- quality improvement
- sars cov
- palliative care
- ejection fraction
- newly diagnosed
- affordable care act
- prognostic factors
- risk factors
- respiratory syndrome coronavirus
- case report
- cardiovascular events
- stem cells
- mental health
- cardiovascular disease
- cell therapy
- mesenchymal stem cells
- health insurance
- patient reported
- social media